Please provide your email address to receive an email when new articles are posted on . President Trump signed an executive order to split up the MMR vaccine into three components. Manufacturers said ...

Andrew covers the biopharma industry, scientific research, and public health across the continent. You can reach Andrew confidentially on Signal at drewqjoseph.71. LONDON — Half a year into taking ...

GE HealthCare and Catholic Health signed a 10-year strategic alliance valued at around $500 million. Dimerix bought an acute kidney injury drug from Mission Therapeutics for $5 million upfront and up ...

Former Novartis leader Nikita Popov joined GSK as SVP, R&D technology transformation and operations. Kristen Corr was promoted to director, channel strategy, U.S. media at AstraZeneca. AstraZeneca ...

July 8 (Reuters) - Alector said on Wednesday that GSK had terminated their neuroscience collaboration agreement covering two experimental antibody drugs after both the drug candidates suffered ...

GSK and Spero Therapeutics have scored an FDA approval for Utebzi as the first oral carbapenem antibiotic for complicated urinary tract infections (cUTI). With the nod, patients in the United States ...

Two GlaxoSmithKline (GSK) R&D team members at work in the company’s Upper Merion, PA, laboratory. GSK has agreed to acquire Nuvalent for $10.6 billion, in a deal designed to strengthen the buyer’s ...

This story is republished from STAT, the health and medicine news site that’s a partner to the Globe. Sign up for STAT’s free Morning Rounds newsletter here. LONDON — GSK said Tuesday it would buy the ...

Andrew covers the biopharma industry, scientific research, and public health across the continent. You can reach Andrew confidentially on Signal at drewqjoseph.71. LONDON — GSK said Tuesday it would ...

GSK has struck a deal to buy Nuvalent for $10.6 billion, securing two near-approval cancer therapies that could challenge products from Roche, Pfizer and other drugmakers. The FDA is set to rule on ...

U.K. pharmaceutical group GSK has entered an agreement to acquire U.S.-based specialist oncology biotech Nuvalent for $10.6 billion. The acquisition could help GSK offset a drop in revenue expected ...

GSK remains in focus after recent pipeline news and ongoing US litigation discussions around heartburn drug Zantac, while investors weigh the company’s vaccines and specialty medicines growth story ...